Kehl KL, Schrag D, Hassett MJ, Uno H. Assessment of Temporal Selection Bias in Genomic Testing in a Cohort of Patients With Cancer. JAMA Netw Open. 2020 Jun 01; 3(6):e206976.
View in:
PubMed
Vaz-Luis I, Barroso-Sousa R, Di Meglio A, Hu J, Rees R, Sinclair N, Milisits L, Leone JP, Constantine M, Faggen M, Briccetti F, Block C, O'Neil K, Partridge A, Burstein H, Waks AG, Trippa L, Tolaney SM, Hassett M, Winer EP, Lin NU. Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study. J Clin Oncol. 2020 Apr 24; JCO1902484.
View in:
PubMed
Hassett MJ, Li H, Burstein HJ, Punglia RS. Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes. Breast Cancer Res Treat. 2020 May; 181(1):43-51.
View in:
PubMed
Hassett MJ, Somerfield MR, Giordano SH. Management of Male Breast Cancer: ASCO Guideline Summary. JCO Oncol Pract. 2020 Feb 24; JOP1900792.
View in:
PubMed
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol. 2020 Jun 01; 38(16):1849-1863.
View in:
PubMed
Ozanne EM, Soeteman DI, Frank ES, Clarke J, Hassett MJ, Stout NK, Punglia RS. Commentary: Creating a patient-centered decision aid for ductal carcinoma in situ. Breast J. 2020 Feb 08.
View in:
PubMed
Kehl KL, Hassett MJ, Schrag D. Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era. Cancer Med. 2020 Mar; 9(6):2019-2029.
View in:
PubMed
Smyth LM, Zhou Q, Nguyen B, Yu C, Lepisto EM, Arnedos M, Hasset MJ, Lenoue-Newton ML, Blauvelt N, Dogan S, Micheel CM, Wathoo C, Horlings H, Hudecek J, Gross BE, Kundra R, Sweeney SM, Gao J, Schultz N, Zarski A, Gardos SM, Lee J, Sheffler-Collins S, Park BH, Sawyers CL, André F, Levy M, Meric-Bernstam F, Bedard PL, Iasonos A, Schrag D, Hyman DM. Characteristics and Outcome of AKT1E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry. Cancer Discov. 2020 Apr; 10(4):526-535.
View in:
PubMed
Uno H, Horiguchi M, Hassett MJ. Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. Oncologist. 2020 Feb; 25(2):91-93.
View in:
PubMed
Uno H, Horiguchi M, Hassett MJ. Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. Oncologist. 2019 Nov 19.
View in:
PubMed
Kehl KL, Elmarakeby H, Nishino M, Van Allen EM, Lepisto EM, Hassett MJ, Johnson BE, Schrag D. Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports. JAMA Oncol. 2019 Jul 25.
View in:
PubMed
Hassett MJ, Banegas M, Uno H, Weng S, Cronin AM, O'Keeffe Rosetti M, Carroll NM, Hornbrook MC, Ritzwoller DP. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease. J Oncol Pract. 2019 07; 15(7):e616-e627.
View in:
PubMed
Carroll NM, Ritzwoller DP, Banegas MP, O'Keeffe-Rosetti M, Cronin AM, Uno H, Hornbrook MC, Hassett MJ. Performance of Cancer Recurrence Algorithms After Coding Scheme Switch From International Classification of Diseases 9th Revision to International Classification of Diseases 10th Revision. JCO Clin Cancer Inform. 2019 03; 3:1-9.
View in:
PubMed
Uno H, Ritzwoller DP, Cronin AM, Carroll NM, Hornbrook MC, Hassett MJ. Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record Data. JCO Clin Cancer Inform. 2018 12; 2:1-10.
View in:
PubMed
Sinaiko AD, Chien AT, Hassett MJ, Kakani P, Rodin D, Meyers DJ, Fraile B, Rosenthal MB, Landrum MB. What drives variation in spending for breast cancer patients within geographic regions? Health Serv Res. 2019 02; 54(1):97-105.
View in:
PubMed
Zhang B, Lloyd W, Jahanzeb M, Hassett MJ. Use of Patient-Reported Outcome Measures in Quality Oncology Practice Initiative-Registered Practices: Results of a National Survey. J Oncol Pract. 2018 10; 14(10):e602-e611.
View in:
PubMed
Horiguchi M, Hassett MJ, Uno H. How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated? Oncologist. 2019 07; 24(7):867-871.
View in:
PubMed
Lin NU, Bichkoff H, Hassett MJ. Increasing Burden of Prior Authorizations in the Delivery of Oncology Care in the United States. J Oncol Pract. 2018 09; 14(9):525-528.
View in:
PubMed
Ritzwoller DP, Fishman PA, Banegas MP, Carroll NM, O'Keeffe-Rosetti M, Cronin AM, Uno H, Hornbrook MC, Hassett MJ. Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis. Health Serv Res. 2018 12; 53(6):5106-5128.
View in:
PubMed
Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller DP. Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer. JNCI Cancer Spectr. 2018 Apr; 2(2):pky024.
View in:
PubMed
Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS. Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Res Treat. 2018 Oct; 171(3):777-781.
View in:
PubMed
Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Somerfield MR, Trudeau ME, Wolff AC, Giordano SH. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2018 08 10; 36(23):2433-2443.
View in:
PubMed
Hassett MJ, Jiang W, Hughes ME, Edge S, Javid SH, Niland JC, Theriault R, Wong YN, Schrag D, Punglia RS. Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018 04; 16(4):387-394.
View in:
PubMed
Weingart SN, Zhang L, Sweeney M, Hassett M. Chemotherapy medication errors. Lancet Oncol. 2018 04; 19(4):e191-e199.
View in:
PubMed
Ritzwoller DP, Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Kushi LC. Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm. J Natl Cancer Inst. 2018 03 01; 110(3):273-281.
View in:
PubMed
Uno H, Hassett MJ, Wei LJ. Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer. JAMA. 2018 01 16; 319(3):306.
View in:
PubMed
Poorvu PD, Vaz-Luis I, Freedman RA, Lin NU, Barry WT, Winer EP, Hassett MJ. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States. Breast Cancer Res Treat. 2018 Apr; 168(3):727-737.
View in:
PubMed
Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D. Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2017 12; 55(12):e88-e98.
View in:
PubMed
Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat. 2018 02; 167(3):751-759.
View in:
PubMed
Hassett MJ. Usability Considerations in Oncology Electronic Medical Records. J Oncol Pract. 2017 08; 13(8):539-541.
View in:
PubMed
Chen CT, Li L, Brooks G, Hassett M, Schrag D. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death. Health Serv Res. 2018 08; 53(4):2118-2132.
View in:
PubMed
Hassett MJ. Quality Improvement in the Era of Big Data. J Clin Oncol. 2017 10 01; 35(28):3178-3180.
View in:
PubMed
Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Fishman P, Ritzwoller DP. Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol. 2017 08; 49:186-194.
View in:
PubMed
Lynch JA, Berse B, Petkov V, Filipski K, Zhou Y, Khoury MJ, Hassett M, Freedman AN. Implementation of the 21-gene recurrence score test in the United States in 2011. Genet Med. 2016 10; 18(10):982-90.
View in:
PubMed
Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Breast Cancer Res Treat. 2016 Feb; 155(3):569-78.
View in:
PubMed
Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Res Treat. 2016 Feb; 155(3):541-9.
View in:
PubMed
Ganz PA, Hassett MJ, Miller DC. Challenges and Opportunities in Delivering High-Quality Cancer Care: A 2016 Update. Am Soc Clin Oncol Educ Book. 2016; 35:e294-300.
View in:
PubMed
Hassett MJ, Schymura MJ, Chen K, Boscoe FP, Gesten FC, Schrag D. Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment. Cancer. 2016 Feb 01; 122(3):420-31.
View in:
PubMed
Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D. Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2015 Jul 29.
View in:
PubMed
Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):622-30.
View in:
PubMed
Vaz-Luis I, Hughes ME, Cronin AM, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study. Cancer. 2015 Jun 15; 121(12):1937-48.
View in:
PubMed
Brooks GA, Li L, Uno H, Hassett MJ, Landon BE, Schrag D. Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer. Health Aff (Millwood). 2014 Oct; 33(10):1793-800.
View in:
PubMed
Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, Schrag D, Warren JL, Hornbrook MC, Weeks JC. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73.
View in:
PubMed
Hassett MJ, Neville BA, Weeks JC. The relationship between quality, spending and outcomes among women with breast cancer. J Natl Cancer Inst. 2014 Oct; 106(10).
View in:
PubMed
Hassett MJ, McNiff KK, Dicker AP, Gilligan T, Hendricks CB, Lennes I, Murray T, Krzyzanowska MK. High-priority topics for cancer quality measure development: results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit. J Oncol Pract. 2014 May; 10(3):e160-6.
View in:
PubMed
Dalby CK, Anastas S, Brady L, Hassett MJ, Shulman LN, Jacobson JO. Implementation of chemotherapy treatment plans (CTP) in a large comprehensive cancer center (CCC): The key roles of infrastructure and data sharing. J Clin Oncol. 2013 Nov; 31(31_suppl):20.
View in:
PubMed
Shin J, Liang SY, Hassett MJ, Phillips KA, Haas JS. Utilization of cardiac monitoring tests in women with nonmetastatic breast cancer treated with trastuzumab. Per Med. 2013 Sep; 10(7):703-708.
View in:
PubMed
Hassett MJ, Elkin EB. What does breast cancer treatment cost and what is it worth? Hematol Oncol Clin North Am. 2013 Aug; 27(4):829-41, ix.
View in:
PubMed
Weingart SN, Zhu J, Young-Hong J, Vermilya HB, Hassett M. Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior? J Oncol Pharm Pract. 2014 Jun; 20(3):163-71.
View in:
PubMed
Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst. 2013 Jun 05; 105(11):774-81.
View in:
PubMed
Brooks GA, Li L, Sharma DB, Weeks JC, Hassett MJ, Yabroff KR, Schrag D. Regional variation in spending and survival for older adults with advanced cancer. J Natl Cancer Inst. 2013 May 01; 105(9):634-42.
View in:
PubMed
Hassett MJ, Wheelock A, Thorsen CM, Kaplan C, Ozanne E. Cost of cancer care: The impact of disclosure on willingness to pay and treatment preferences. J Clin Oncol. 2012 Dec; 30(34_suppl):15.
View in:
PubMed
Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC. Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions. Cancer. 2013 Mar 01; 119(5):1065-72.
View in:
PubMed
Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett M. Improving electronic oral chemotherapy prescription: can we build a safer system? J Oncol Pract. 2012 Nov; 8(6):e168-73.
View in:
PubMed
Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PJ, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D. Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst. 2012 Jul 18; 104(14):1102-5.
View in:
PubMed
Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer. 2012 Dec 15; 118(24):6022-30.
View in:
PubMed
Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC. Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol. 2012 Jun 20; 30(18):2218-26.
View in:
PubMed
Weingart SN, Li JW, Zhu J, Morway L, Stuver SO, Shulman LN, Hassett MJ. US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards. J Oncol Pract. 2012 Jan; 8(1):7-12.
View in:
PubMed
Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN. Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 2011 Dec; 37(12):568-75.
View in:
PubMed
Brawarsky P, Neville BA, Fitzmaurice GM, Hassett MJ, Haas JS. Use of annual mammography among older women with ductal carcinoma in situ. J Gen Intern Med. 2012 May; 27(5):500-5.
View in:
PubMed
Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med. 2011 Oct; 13(10):853-60.
View in:
PubMed
Arnaout A, Leblebjian H, Bartel S, Hassett MJ. Relative dose intensity (RDI) assessment in an academic center. J Clin Oncol. 2011 Sep 20; 29(27_suppl):139.
View in:
PubMed
Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat. 2011 Nov; 130(2):619-26.
View in:
PubMed
Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PR, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D. Adjuvant hormone therapy use in early-stage breast cancer patients insured by the New York State Medicaid program. J Clin Oncol. 2011 May 20; 29(15_suppl):6031.
View in:
PubMed
Hassett MJ, Neville BA, Weeks JC. The relationship between cost, quality, and outcomes among women with breast cancer in SEER-Medicare. J Clin Oncol. 2011 May 20; 29(15_suppl):6001.
View in:
PubMed
Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong Y, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers (SBC) among women previously treated for ductal carcinoma in situ (DCIS) with breast conservation. J Clin Oncol. 2011 May 20; 29(15_suppl):1042.
View in:
PubMed
Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract. 2011 May; 7(3 Suppl):e1s-7s.
View in:
PubMed
Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care. 2011 May 01; 17(5 Spec No):e174-81.
View in:
PubMed
Hassett MJ, Rao SR, Brozovic S, Stahl JE, Schwartz JH, Maloney B, Jacobson JO. Chemotherapy-related hospitalization among community cancer center patients. Oncologist. 2011; 16(3):378-87.
View in:
PubMed
Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC. Impact of neoadjuvant chemotherapy on breast reconstruction. Cancer. 2011 Jul 01; 117(13):2833-41.
View in:
PubMed
Punglia RS, Hassett MJ. Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol. 2010 Sep 20; 28(27):4108-10.
View in:
PubMed
Hassett MJ. The full burden of cancer. Oncologist. 2010; 15(8):793-5.
View in:
PubMed
Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL. Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer. 2009 Nov 15; 115(22):5166-74.
View in:
PubMed
Hassett MJ, O'Malley AJ, Keating NL. Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer. 2009 Jun 15; 115(12):2775-82.
View in:
PubMed
Haas J, Phillips KA, Hassett MJ, Liang S, Keohane C, Armstrong J, Toscano M. Breast cancer testing strategies and the utilization of targeted therapies: Data from the real world. J Clin Oncol. 2009 May 20; 27(15_suppl):e17518.
View in:
PubMed
Rao SR, Hassett M, Schwartz JH, Maloney B, Jacobson JO. Admissions for chemotherapy-related serious adverse effects (CR-SAEs) and rates of mortality among community cancer center patients. J Clin Oncol. 2009 May 20; 27(15_suppl):6571.
View in:
PubMed
Hassett MJ, Weeks JC. Identifying high-priority quality measures for breast cancer quality improvement using data from a nationally representative sample. J Clin Oncol. 2009 May 20; 27(15_suppl):6507.
View in:
PubMed
Hassett MJ, Griggs JJ. Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no. J Clin Oncol. 2009 May 01; 27(13):2120-1.
View in:
PubMed
Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer. 2009 Feb 15; 115(4):716-24.
View in:
PubMed
Azzone V, Frank RG, Pakes JR, Earle CC, Hassett MJ. Behavioral health services for women who have breast cancer. J Clin Oncol. 2009 Feb 10; 27(5):706-12.
View in:
PubMed
Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer. J Clin Oncol. 2008 Dec 01; 26(34):5553-60.
View in:
PubMed
Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Selecting high priority quality measures for breast cancer quality improvement. Med Care. 2008 Aug; 46(8):762-70.
View in:
PubMed
Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst. 2006 Aug 16; 98(16):1108-17.
View in:
PubMed
Hassett MJ, Pakes J, O'Malley AJ, Newhouse JP, Earle CC. Chemotherapy-related serious adverse events and health care expenditures among commercially insured women with breast cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):6000.
View in:
PubMed
Leo RJ, Burnett GJ, Hassett MJ. Psychosis associated with hypopituitarism. Gen Hosp Psychiatry. 1998 Jul; 20(4):248-54.
View in:
PubMed
Hassett MJ, Glick PL, Karamanoukian HL, Rossman JE, Wilcox DT, Azizkhan RG. Pathophysiology of congenital diaphragmatic hernia. XVI: Elevated pulmonary collagen in the lamb model of congenital diaphragmatic hernia. J Pediatr Surg. 1995 Aug; 30(8):1191-4.
View in:
PubMed